- Stewart, currently CEO of Phylogica, has more than 12 years experience in the biotechnology industry, having founded and formed a number of successful biotechnology companies and bringing them to sustained profitability. He also has extensive international capital market experience, having raised over $38 million in private shareholder and government funds. Prior to his appointment at Phylogica, Stuart was Chief Executive Officer of Celentis Ltd. Here, he managed the commercialisation of intellectual property from the largest Crown Research Institute in New Zealand with 650 scientists and $130 million in revenues.
- During this time he formed and governed a number of successful biotechnology companies that employed over 100 staff and realized profitable annual product revenues of $30 million per annum. Before this he was based in Australia where he also formed a number of successful biotechnology companies.
Back
